Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar for Transplant Glomerulopathy
NCT02057523Phase 4Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Sep 2014
- Primary completion
- Mar 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of corticotropin in transplant glomerulopathy (TG), sponsored by University of Illinois Chicago. Started Sep 2014; status: terminated.
02
Drugs
corticotropin
03
Conditions
transplant glomerulopathy (TG)
Beyond the preview
Go deeper on NCT02057523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057523.